A Multicenter, Single-arm, Open, Phase II Clinical Study on the Efficacy and Safety of Toripalimab(JS001) After Chemotherapy in Combination With Endostar in Patients With Unresectable Locally Advanced or Metastatic Mucosal Melanoma
Latest Information Update: 27 Jun 2023
At a glance
- Drugs Toripalimab (Primary) ; Endostatin
- Indications Malignant melanoma
- Focus Therapeutic Use
- Acronyms MTAM
- 17 Jul 2020 New trial record